Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Clinical and Vaccine Immunology : CVI|July 28, 2012
Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysisMoustafa Moustafa, George R Aronoff, Chandra Chandran, et al.Antimicrobial Agents and Chemotherapy|December 31, 2008
Pharmacokinetics and safety of caspofungin in older infants and toddlersMichael Neely, Hasan S Jafri, Nita Seibel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapyJohan Maertens, Issam Raad, George Petrikkos, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell TransplantationPer Ljungman, Michael Schmitt, Francisco M Marty, et al.Plos One|March 27, 2019
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropeniaAntonio C Arrieta, Lillian Sung, John S Bradley, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2015
Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosisMasaaki Mori, Masue Imaizumi, Naruhiko Ishiwada, et al.The Pediatric Infectious Disease Journal|September 26, 2009
Safety experience with caspofungin in pediatric patientsTheoklis Zaoutis, Thomas Lehrnbecher, Andreas H Groll, et al.Antimicrobial Agents and Chemotherapy|December 17, 2008
Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of ageXavier Sáez-Llorens, Mercedes Macias, Padmanabha Maiya, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2009
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasisRobert F Betts, Marcio Nucci, Deepak Talwar, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsThomas J Walsh, Peter C Adamson, Nita L Seibel, et al.Pageof 4